These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 1469784

  • 21. [Polyclonal B-cell lymphocytosis with clinical and hematological features resembling hairy cell leukemia].
    Kanbayashi H, Nagata K, Tanaka T, Matsuda S, Sakuma H, Maruyama Y, Machii T.
    Rinsho Ketsueki; 1998 Jul; 39(7):493-8. PubMed ID: 9750456
    [Abstract] [Full Text] [Related]

  • 22. [A hairy B cell lymphoproliferative disorder resembling hairy cell leukemia].
    Yagi Y, Sakabe H, Kakinoki R, Yoshikawa K, Inoue T, Fujiyama Y, Machii T.
    Rinsho Ketsueki; 2004 Apr; 45(4):312-5. PubMed ID: 15168448
    [Abstract] [Full Text] [Related]

  • 23. Successful treatment of patients with hairy cell leukemia (HCL) using a single cycle of 2-chloro-2'-deoxyadenosine (CdA).
    Jehn U, Gawaz M, Grunewald R, Hill W, Lorenz B, Stôtzer O.
    Anticancer Res; 1993 Apr; 13(5C):1809-14. PubMed ID: 7903521
    [Abstract] [Full Text] [Related]

  • 24. The treatment of hairy cell leukemia (HCL) with pentostatin (2'-deoxycoformycin, dCF).
    Spiers AS, Parekh SJ.
    Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():173-5. PubMed ID: 2653498
    [No Abstract] [Full Text] [Related]

  • 25. Minimal residual disease in hairy-cell leukemia after treatment with 2-chlorodeoxyadenosine.
    Konwalinka G, Schirmer M, Hilbe W, Fend F, Geisen F, Knoblechner A, Petzer A, Thaler J.
    Blood Cells Mol Dis; 1995 Jan; 21(2):142-51. PubMed ID: 8846043
    [Abstract] [Full Text] [Related]

  • 26. [Hairy cell leukemia of European-American type with dual T and B-cell phenotype].
    Kurosawa M, Maekawa I, Kawamura T, Miyake T, Machii T, Kitani T, Tokumine Y, Kawa K.
    Rinsho Ketsueki; 1989 Jun; 30(6):892-7. PubMed ID: 2795901
    [Abstract] [Full Text] [Related]

  • 27. Long-term outcome following treatment of hairy cell leukemia with pentostatin (Nipent): a National Cancer Institute of Canada study.
    Johnston JB, Eisenhauer E, Wainman N, Corbett WE, Zaentz SD, Daeninck PJ.
    Semin Oncol; 2000 Apr; 27(2 Suppl 5):32-6. PubMed ID: 10877049
    [Abstract] [Full Text] [Related]

  • 28. [Successful treatment with cladribine for hypoplastic hairy cell leukemia after long-term neutropenia].
    Sakai R, Yamazaki E, Sakamoto H, Kanamori H, Ishigatsubo Y.
    Rinsho Ketsueki; 2005 Nov; 46(11):1187-90. PubMed ID: 16440801
    [Abstract] [Full Text] [Related]

  • 29. The diagnosis of hairy cell leukemia can be established by flow cytometric analysis of peripheral blood, even in patients with low levels of circulating malignant cells.
    Cornfield DB, Mitchell Nelson DM, Rimsza LM, Moller-Patti D, Braylan RC.
    Am J Hematol; 2001 Aug; 67(4):223-6. PubMed ID: 11443633
    [Abstract] [Full Text] [Related]

  • 30. Hairy cell leukemia: current concepts.
    Cannon T, Mobarek D, Wegge J, Tabbara IA.
    Cancer Invest; 2008 Oct; 26(8):860-5. PubMed ID: 18798068
    [Abstract] [Full Text] [Related]

  • 31. Clinical experience with 2'-deoxycoformycin.
    Catovsky D.
    Hematol Cell Ther; 1996 Dec; 38 Suppl 2():S103-7. PubMed ID: 9137963
    [Abstract] [Full Text] [Related]

  • 32. [Improvement with interferon-alpha therapy and splenectomy in hairy cell leukemia of European-American type].
    Yasuyama M, Kawauchi K, Sugiyama H, Mori H, Enomoto Y, Watanabe Y, Machii T, Kitani T.
    Rinsho Ketsueki; 1992 Mar; 33(3):365-70. PubMed ID: 1578641
    [Abstract] [Full Text] [Related]

  • 33. Pentostatin (Nipent) in T-cell malignancies. Leukemia Cooperative Group and the European Organization for Research and Treatment of Cancer.
    Ho AD, Suciu S, Stryckmans P, De Cataldo F, Willemze R, Thaler J, Peetermans M, Döhner H, Solbu G, Dardenne M, Zittoun R.
    Semin Oncol; 2000 Apr; 27(2 Suppl 5):52-7. PubMed ID: 10877053
    [Abstract] [Full Text] [Related]

  • 34. Treatment of hairy cell leukemia: the Ohio State University experience with deoxycoformycin.
    Bouroncle BA, Grever MR, Kraut EH.
    Leukemia; 1987 Apr; 1(4):350-4. PubMed ID: 3499542
    [Abstract] [Full Text] [Related]

  • 35. Deoxycoformycin: an active new drug for indolent lymphomas and hairy cell leukemia.
    O'Dwyer PJ, Cheson BD, Leyland-Jones B, King SA, Hoth DF.
    Oncology (Williston Park); 1988 Jun; 2(6):17-23, 26-7. PubMed ID: 3079330
    [Abstract] [Full Text] [Related]

  • 36. Simultaneous manifestation of chronic lymphocytic leukemia (CLL) and hairy cell leukemia (HCL).
    Sokol L, Agosti SJ.
    Am J Hematol; 2004 Feb; 75(2):107-9. PubMed ID: 14755378
    [Abstract] [Full Text] [Related]

  • 37. Development of hairy cell leukemia in a patient with antiphospholipid syndrome.
    Diz-Kucukkaya R, Dincol G, Kamali S, Kural F, Inanc M.
    Lupus; 2007 Feb; 16(4):286-8. PubMed ID: 17439936
    [Abstract] [Full Text] [Related]

  • 38. Hairy-cell leukemia variant: recent view on diagnosis, biology and treatment.
    Robak T.
    Cancer Treat Rev; 2011 Feb; 37(1):3-10. PubMed ID: 20558005
    [Abstract] [Full Text] [Related]

  • 39. Successful treatment of aplastic variant of hairy-cell leukaemia with deoxycoformycin.
    Ng JP, Nolan B, Chan-Lam D, Coup AJ, McKenna D.
    Hematology; 2002 Aug; 7(4):259-62. PubMed ID: 14972788
    [Abstract] [Full Text] [Related]

  • 40. Glucose metabolism of hairy cells.
    Kraut EH, Husney RM, Sagone AL.
    Leukemia; 1992 Aug; 6(8):834-8. PubMed ID: 1640737
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.